Skip to content

Acadia Pharmaceuticals ACAD Investment Purchases

Investment Purchases at other companies

Biogen logo
BiogenBIIB
$748.8M
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$819.5M+200%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$454.67M+41.1%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$52.67M
Arrowhead Research logo
Arrowhead ResearchARWR
$924.64M+43.5%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$554.43M+41.7%

Other financials

Income statement

See full
Revenue$268.1M+9.7%
Gross profit$243.3M+8.6%
Operating income-$4.6M-124%
Net income$3.6M-80.8%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$282.2M+29.6%
Total debt$50.8M-9.3%
Total equity$1.2B+63.1%
Total assets$1.6B+41.8%

Cash flow

See full
Operating cash flow$34.0M+67.2%
CapEx$5.2M
Free cash flow$28.8M+41.6%

Valuation

See full
Market cap$3.87B+37.0%

Profitability

See full
Gross margin91.5%-0.6pp
Operating margin7.4%-16.2pp
Net margin34.3%+11.3pp
FCF margin18.9%

Returns & leverage

See full
Return on equity37.3%+0.1pp
Debt / equity0.0×
Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Acadia Pharmaceuticals's investment purchases?
Acadia Pharmaceuticals (ACAD) reported investment purchases of $15.01M in Q1 2026.
How has Acadia Pharmaceuticals's investment purchases changed year-over-year?
Acadia Pharmaceuticals's investment purchases decreased by 90.4% year-over-year, from $156.01M to $15.01M.
What is the long-term trend for Acadia Pharmaceuticals's investment purchases?
Over 4 years (2021 to 2025), Acadia Pharmaceuticals's investment purchases has grown at a 8.9% compound annual growth rate (CAGR), from $492.8M to $692.57M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.